These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25888306)

  • 21. Hepatitis C drug affordability.
    Kamal-Yanni M
    Lancet Glob Health; 2015 Feb; 3(2):e73-4. PubMed ID: 25617196
    [No Abstract]   [Full Text] [Related]  

  • 22. US lawmakers seek cuts in prescription drug prices.
    Jaffe S
    Lancet; 2019 Mar; 393(10175):975-976. PubMed ID: 30860040
    [No Abstract]   [Full Text] [Related]  

  • 23. Shades of gray. Secondary drug distributors raise questions.
    Lee J
    Mod Healthc; 2011 Oct; 41(41):10, 12. PubMed ID: 22111494
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 25. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health Insurers Often Foot Bill When Drug Coupons Are Used.
    Wolinsky H
    Manag Care; 2017 Mar; 26(3):38-39. PubMed ID: 28510519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicare Part D update--lessons learned and unfinished business.
    Neuman P; Cubanski J
    N Engl J Med; 2009 Jul; 361(4):406-14. PubMed ID: 19625722
    [No Abstract]   [Full Text] [Related]  

  • 28. How insurers' bargaining power affects drug prices in Medicare Part D.
    Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
    [No Abstract]   [Full Text] [Related]  

  • 29. Slowdown in prescription drug spending won't last.
    Manag Care; 2013 Nov; 22(11):49. PubMed ID: 24409532
    [No Abstract]   [Full Text] [Related]  

  • 30. The growth of prescription drug costs and national health expenditures.
    Cole DL
    Med Interface; 1995 Mar; 8(3):42-3. PubMed ID: 10141387
    [No Abstract]   [Full Text] [Related]  

  • 31. Global spending on prescription drugs to top $1 trillion by 2017, report says.
    McCarthy M
    BMJ; 2013 Nov; 347():f6997. PubMed ID: 24264569
    [No Abstract]   [Full Text] [Related]  

  • 32. Trends in prescribed medicine use and spending by older Americans, 1992-2001.
    Goulding MR
    Aging Trends; 2005 Feb; (5):1-10. PubMed ID: 19174842
    [No Abstract]   [Full Text] [Related]  

  • 33. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Economics of Indication-Based Drug Pricing.
    Chandra A; Garthwaite C
    N Engl J Med; 2017 Jul; 377(2):103-106. PubMed ID: 28700848
    [No Abstract]   [Full Text] [Related]  

  • 35. State Initiatives to Control Medication Costs--Can Transparency Legislation Help?
    Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2016 Jun; 374(24):2301-4. PubMed ID: 27305189
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug expenditure in Ireland 1997-2007.
    Barry M; Molloy D; Usher C; Tilson L
    Ir Med J; 2008; 101(10):299-302. PubMed ID: 19205138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
    Lee J
    Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044228
    [No Abstract]   [Full Text] [Related]  

  • 38. An explanatory model for state Medicaid per capita prescription drug expenditures.
    Roy S; Madhavan SS
    Soc Work Public Health; 2012; 27(6):537-53. PubMed ID: 22963157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Health" care in crisis.
    Miller AL
    Altern Med Rev; 2007 Jun; 12(2):97. PubMed ID: 19760822
    [No Abstract]   [Full Text] [Related]  

  • 40. Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program.
    Jones EA; Linas BP; Truong V; Burgess JF; Lasser KE
    PLoS One; 2019; 14(3):e0213745. PubMed ID: 30870475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.